Chronic Kidney Disease Trial, Recruiting NCT07413315 Sponsor: Brugmann University Hospital Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07413315
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have end-stage (terminal) kidney disease and are currently receiving hemodialysis (a machine that filters the blood)
  • People who have recently been admitted to hospital for a sudden or serious medical event

Who may not be able to join:

  • People who have dementia or significant memory and thinking difficulties (based on a standard mental assessment score below 20 out of 30)
  • People who have an active or unstable psychiatric condition or significant behavioural difficulties
  • People who are pregnant
  • People whose kidney function has recovered enough that hemodialysis is no longer needed
  • People who are scheduled for neurological rehabilitation (rehabilitation related to the brain or nervous system)
  • People who have recently had a spinal cord injury
  • People for whom an exercise stress test (a supervised test that monitors the heart during physical effort) is considered unsafe, either fully or partially
  • People who have a serious heart rhythm problem that is not well managed
  • People who have a severe or symptomatic blockage affecting how blood flows out of the heart's main pumping chamber
  • People whose heart failure is currently unstable or not controlled
  • People who have active inflammation of the heart muscle, the sac around the heart, or the heart valves
  • People who have a recent tear in the wall of the main blood vessel leading from the heart (aortic dissection)
  • People who have a blood clot inside the heart that carries a high risk of travelling elsewhere in the body
  • People who have a significant narrowing of a major coronary artery (the common trunk)
  • People who have a bulging or weakened area in a heart chamber (ventricular aneurysm)
  • People who have a fast irregular heart rhythm originating in the upper chambers of the heart that is not well controlled, or a high-degree or complete blockage of the heart's electrical signals
  • People who have a type of heart muscle thickening that causes a significant blockage to blood flow at rest
  • People who have recently had a stroke or a brief stroke-like episode (TIA)
  • People who have a recent blood clot in a vein, with or without a clot in the lungs
  • People whose overall health condition is poorly controlled, such as severe anaemia, significant abnormalities in blood salt levels, or an overactive thyroid gland
  • People who are unable or unwilling to cooperate with the study requirements
  • People whose blood pressure is above 200/110 mmHg

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joris Vanparys, MD, CHU Brugmann

Phone: +32 2475 52 64

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Brugmann University Hospital
Registry
ClinicalTrials.gov
Start date
13 August 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Hand grip test; Hand grip test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov